Molecular Imaging and Applications for Pharmaceutical R&D

Evaluation of a 99mTc-Labeled AnnexinA5 Variant for Non-invasive SPECT Imaging of Cell Death in Liver, Spleen and Prostate

“…Due to their application to human studies, nuclear imaging assessments can provide relevant clinical information at an early stage during drug development, assist in the generation of data, which can be translated from preclinical research to clinical development, and potentially provide surrogate endpoints in clinical trials. Applying a non-invasive longitudinal scan approach in pre-clinical pharmacological research may also contribute to a reduction in the use of experimental animals (1)(2)(3).…”